13 Nov 2025 · 1 min read
AbbVie is quietly unwinding its 11 year longevity bet with Google's (Alphabet's) Calico Life Scie...
AbbVie is quietly unwinding its 11-year longevity bet with Google's (Alphabet's) Calico Life Sciences — a $1.5B collaboration started in 2014 around aging and age-related disease. I don't think this particular setback signals something more fundamental, but it raises real questions about where dedicated drug development in longevity is headed.